Incident Hypertension with Antiretroviral Therapy in the OPERA Cohort
Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2026-01 · 25
DOI: 10.1177/23259582261445148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), online erschienen am 23.04.2026. Verfasst von Gerald Pierone und 10 weiteren Autor:innen. Beteiligte Einrichtung: Whole Family Health Center, Vero Beach, FL, USA. Hauptthemen laut MEDLINE: HIV Infections, Hypertension, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ViiV Healthcare.
Abstract (Originalsprache)
Purpose of the research To compare incident hypertension rates across antiretroviral therapy regimens among adults with HIV in routine clinical care in the US-based OPERA cohort. Major findings The hypertension incidence rate was 4.16 per 100 person-years (95% CI: 3.75, 4.61) among 3220 ART-naïve individuals, and 4.60 (95% CI: 3.99, 5.30) among 1442 ART-experienced individuals. There was no statistically significant difference in incident hypertension between regimens at the class-level (integrase inhibitor with/without tenofovir alafenamide (TAF), boosted protease inhibitor, and non-nucleoside reverse transcriptase inhibitor) nor the drug-level (dolutegravir three-drug regimen with/without TAF, dolutegravir/lamivudine, bictegravir/emtricitabine/TAF, and boosted darunavir with TAF three-drug regimen). Conclusions In this large cohort representing routine clinical care in the USA, classes of antiretrovirals and specific agent combinations with or without TAF were not statistically significantly associated with incident hypertension. Other factors are likely to be more important drivers of hypertension than antiretroviral therapy selection in people with HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Whole Family Health Center, Vero Beach, FL, USA.
- Epividian, Inc., Raleigh, NC, USA.
- Wake Forest University School of Medicine*, Winston-Salem, NC, USA.
- AIDS Healthcare Foundation, Miami, FL, USA.
- Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- ViiV Healthcare, Durham, NC, USA.
ORCID-Profile: Laurence Brunet, Jennifer S Fusco
Förderung
- ViiV Healthcare
Zitieren
APA
Pierone, G., Brunet, L., Fusco, J. S., Lackey, P. C., Wohlfeiler, M. B., Dieterich, D. T., Henegar, C., Vannappagari, V., Jones, B., de Ruiter, A., & Fusco, G. P. (2026). Incident Hypertension with Antiretroviral Therapy in the OPERA Cohort. Journal of the International Association of Providers of AIDS Care (JIAPAC), 25. https://doi.org/10.1177/23259582261445148
Vancouver
Pierone G, Brunet L, Fusco JS, Lackey PC, Wohlfeiler MB, Dieterich DT, et al. Incident Hypertension with Antiretroviral Therapy in the OPERA Cohort. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2026;25. doi:10.1177/23259582261445148
BibTeX
@article{Pierone2026,
author = {Pierone, Gerald and Brunet, Laurence and Fusco, Jennifer S and Lackey, Philip C and Wohlfeiler, Michael B and Dieterich, Douglas T and Henegar, Cassidy and Vannappagari, Vani and Jones, Bryn and de Ruiter, Annemiek and Fusco, Gregory P},
title = {Incident Hypertension with Antiretroviral Therapy in the OPERA Cohort},
journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
year = {2026},
volume = {25},
doi = {10.1177/23259582261445148}
}
EUVIMED